title: Allogeneic Platelet-Rich Plasma: At the Dawn of an Off-the-Shelf Therapy?
abstract: A new therapeutic tool is emerging based on a biomimetic strategy: platelet-rich plasma (PRP) technology. Allogeneic off-the-shelf PRP represents a safe and cost-effective treatment for osteoarthritis and related diseases. This breakthrough opens the door not only to improved treatments and opportunities but also to new challenges with multiple uncertainties.
authors.affiliation: Eduardo Anitua Foundation for Biomedical Research, Vitoria, Spain; BTI-Biotechnology Institute, Vitoria, Spain.
authors.forename: Eduardo
authors.initials: E
authors.lastname: Anitua
authors.affiliation: BTI-Biotechnology Institute, Vitoria, Spain.
authors.forename: Roberto
authors.initials: R
authors.lastname: Prado
authors.affiliation: Eduardo Anitua Foundation for Biomedical Research, Vitoria, Spain; BTI-Biotechnology Institute, Vitoria, Spain; Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (EHU), Vitoria, Spain; Networking Biomedical Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), SLFPB-EHU, Vitoria, Spain. Electronic address: gorka.orive@ehu.es.
authors.forename: Gorka
authors.initials: G
authors.lastname: Orive
mesh_terms: D001802:Blood Substitutes / Q000737:chemistry* / Q000627:therapeutic use*; D006801:Humans; D010003:Osteoarthritis / Q000097:blood / Q000628:therapy*; D053657:Platelet-Rich Plasma / Q000737:chemistry* / Q000378:metabolism*; D014184:Transplantation, Homologous / Q000379:methods*
chemical_list: D001802:Blood Substitutes